Novo Nordisk plans $747.2 M facility expansion
The company aims to create more capacity for R&D activities and the production of APIs
Nova Nordisk | 24/11/2022 | By Sudeep Soparkar | 451
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy